ESAT6-CFP10 recombinant TB allergen
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ESAT6-CFP10 recombinant TB allergen, covering 2015-03-31 to 2015-03-31. Get the full timeline:
Most recent: Clinical Trial Update: Phase I Clinical Human Tolerability Study of Recombinant Mycobacterium Tuberculosis Allergen ESAT6-CFP10 [Phase 1]